ArticleWorld journal of diabetes2024

Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials.

Na Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.